Dual targeting of joint and lung disease: efficacy of tofacitinib plus iguratimod combination in progressive fibrosing rheumatoid arthritis-associated interstitial lung disease
TOF plus IGU demonstrated dual efficacy in controlling synovitis and lung fibrosis, with a favorable safety profile.
Authors
- Weilin Xie (ORCID: https://orcid.org/0000-0001-8432-1853)
- Yingzi Ye
- Wanlin Zhou
- Yuan Zhu
- Xu Zheng
- Zhiying Wu
Institutions
- Police Department (LT)
- Army Sustainment University (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1624125
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00